Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 75 | $12,777,590 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Mar 2025 16:16 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Mar 2025 | Sale | 20,000 | 6.58 | 131,600 | D |
| 07 Mar 2025 16:16 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2025 | Sale | 20,000 | 6.37 | 127,400 | D |
| 07 Feb 2025 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Feb 2025 | Sale | 20,000 | 7.68 | 153,600 | D |
| 07 Feb 2025 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Feb 2025 | Sale | 20,000 | 8.12 | 162,400 | D |
| 13 Jan 2025 17:26 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Jan 2025 | Sale | 20,000 | 7.31 | 146,200 | D |
| 13 Jan 2025 17:26 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 10 Jan 2025 | Sale | 20,000 | 7.05 | 141,000 | D |
| 06 Dec 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Dec 2024 | Sale | 20,000 | 7.16 | 143,200 | D |
| 06 Dec 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Dec 2024 | Sale | 20,000 | 7.12 | 142,400 | D |
| 15 Nov 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 13 Nov 2024 | Sale | 20,000 | 7.74 | 154,800 | D |
| 15 Nov 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 14 Nov 2024 | Sale | 20,000 | 7.35 | 147,000 | D |
| 04 Oct 2024 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Oct 2024 | Sale | 20,000 | 6.16 | 123,200 | D |
| 04 Oct 2024 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Oct 2024 | Sale | 20,000 | 6.08 | 121,600 | D |
| 06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Sep 2024 | Sale | 20,000 | 6.14 | 122,800 | D |
| 06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Sep 2024 | Sale | 20,000 | 6.04 | 120,800 | D |
| 09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Aug 2024 | Sale | 20,000 | 6.5 | 130,000 | D |
| 09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Aug 2024 | Sale | 30,000 | 7.1 | 213,000 | D |
| 12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 11 Jul 2024 | Sale | 50,000 | 7.47 | 373,500 | D |
| 12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 10 Jul 2024 | Sale | 50,000 | 7.48 | 374,000 | D |
| 07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Jun 2024 | Sale | 50,000 | 9 | 450,000 | D |
| 07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jun 2024 | Sale | 50,000 | 8.42 | 421,000 | D |
| 03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 28,704 | 8.47 | 243,123 | D |
| 03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 21,296 | 8.47 | 180,377 | D |
| 03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 May 2024 | Sale | 50,000 | 7.73 | 386,500 | D |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 25,000 | 9.02 | 225,500 | I |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 25,000 | 8.84 | 221,000 | I |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
| 01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
| 01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 1,000 | 11.5621 | 11,562 | I |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 20,000 | 11.5501 | 231,002 | I |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 4,000 | 11.5648 | 46,259 | I |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 36,319 | 11.8583 | 430,682 | D |
| 09 Feb 2024 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Feb 2024 | Sale | 48,272 | 9.2182 | 444,981 | D |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 20,000 | 9.512 | 190,240 | I |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
| 08 Dec 2023 17:22 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Dec 2023 | Sale | 59,829 | 7.4946 | 448,394 | D |
| 03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 1,000 | 5.137 | 5,137 | I |
| 03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 20,000 | 5.1147 | 102,294 | I |
| 03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 4,000 | 5.1411 | 20,564 | I |
| 03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 37,177 | 5.1996 | 193,306 | D |
| 06 Oct 2023 18:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Oct 2023 | Sale | 59,794 | 7.2085 | 431,025 | D |
| 08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 1,000 | 8.8363 | 8,836 | I |
| 08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 20,000 | 8.8348 | 176,696 | I |
| 08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 4,000 | 8.8337 | 35,335 | I |
| 08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 33,765 | 8.7835 | 296,575 | D |
| 04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
| 04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 60,955 | 13.0171 | 793,457 | D |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 13 | 14.85 | 193 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 63 | 13.7541 | 867 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 12.3559 | 1,569 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 561 | 11.8245 | 6,634 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 550 | 14.0291 | 7,716 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 236 | 10.8698 | 2,565 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,693 | 12.4131 | 58,255 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 10,327 | 11.7442 | 121,282 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,430 | 10.8382 | 48,013 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 14.0601 | 1,786 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 12.4076 | 10,546 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 2,173 | 11.8005 | 25,642 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 10.8206 | 9,198 | I |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 17,227 | 14.344 | 247,104 | D |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,270 | 12.3873 | 40,506 | D |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 7,898 | 11.7969 | 93,172 | D |
| 14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,423 | 10.8658 | 37,194 | D |
| 09 Jun 2023 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jun 2023 | Sale | 56,436 | 9.0511 | 510,808 | D |
| 05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 1,000 | 4.9151 | 4,915 | I |
| 05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 20,000 | 4.9018 | 98,036 | I |
| 05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 4,000 | 4.9058 | 19,623 | I |
| 05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 33,073 | 4.7096 | 155,761 | D |
| 28 Apr 2023 16:32 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2022 | Sale A | 18,500 | 7.3875 | 136,669 | D |
| 07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Apr 2023 | Sale | 40,000 | 6.6418 | 265,672 | D |
| 07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Apr 2023 | Sale | 13,327 | 6.4559 | 86,038 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)